Search research articles
Contact Us
Filters
Showing results (191-200 of 258) with videos related to
Page
of 26
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
March 8, 2021
Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia
Eshrak Al-Shaibani, Sunu Cyriac, Shiyi Chen, et al.
European Journal of Haematology
|
June 2, 2021
Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR
Igor Novitzky-Basso, Carol Chen, Shiyi Chen, et al.
Leukemia Research
|
September 21, 2023
Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure
Swe Mar Linn, Igor Novitzky-Basso, Christopher Patriquin, et al.
Hematology/Oncology and Stem Cell Therapy
|
October 13, 2020
Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation
Ram Vasudevan Nampoothiri, Shiyi Chen, Ivan Pasic, et al.
Leukemia & Lymphoma
|
May 14, 2026
CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM - a single center analysis
Vered Stavi, Carol Chen, Igor Novitzky-Basso, et al.
European Journal of Haematology
|
July 14, 2021
Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis
Sunu Cyriac, Shruti Prem, Maria Queralt Salas, et al.
Transplantation and Cellular Therapy
|
May 9, 2021
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation
Maria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
JCO Oncology Practice
|
June 29, 2026
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation
Nihar Desai, Sergio Rodriguez-Rodriguez, Carol Chen, et al.
Blood Cell Therapy
|
January 30, 2023
High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving <i>in vivo</i> T-cell Depletion Transplants and Long-Term Complications
Maria Queralt Salas, Eshetu G Atenafu, Wilson Lam, et al.
Transplantation and Cellular Therapy
|
July 15, 2025
Effect of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide on Graft-Versus-Host Disease Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Leukemia
Nihar Desai, Sergio Rodriguez-Rodriguez, Mats Remberger, et al.
Page
of 26
Search research articles
Search
Showing results (191-200 of 258) with videos related to
Sort By:
Page
of 26
Clinical Lymphoma, Myeloma & Leukemia
|
March 8, 2021
Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia
Eshrak Al-Shaibani, Sunu Cyriac, Shiyi Chen, et al.
European Journal of Haematology
|
June 2, 2021
Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR
Igor Novitzky-Basso, Carol Chen, Shiyi Chen, et al.
Leukemia Research
|
September 21, 2023
Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure
Swe Mar Linn, Igor Novitzky-Basso, Christopher Patriquin, et al.
Hematology/Oncology and Stem Cell Therapy
|
October 13, 2020
Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation
Ram Vasudevan Nampoothiri, Shiyi Chen, Ivan Pasic, et al.
Leukemia & Lymphoma
|
May 14, 2026
CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM - a single center analysis
Vered Stavi, Carol Chen, Igor Novitzky-Basso, et al.
European Journal of Haematology
|
July 14, 2021
Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis
Sunu Cyriac, Shruti Prem, Maria Queralt Salas, et al.
Transplantation and Cellular Therapy
|
May 9, 2021
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation
Maria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
JCO Oncology Practice
|
June 29, 2026
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation
Nihar Desai, Sergio Rodriguez-Rodriguez, Carol Chen, et al.
Blood Cell Therapy
|
January 30, 2023
High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving <i>in vivo</i> T-cell Depletion Transplants and Long-Term Complications
Maria Queralt Salas, Eshetu G Atenafu, Wilson Lam, et al.
Transplantation and Cellular Therapy
|
July 15, 2025
Effect of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide on Graft-Versus-Host Disease Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Leukemia
Nihar Desai, Sergio Rodriguez-Rodriguez, Mats Remberger, et al.
Page
of 26